Dan J. Scungio, MLS (ASCP), SLS, CQA (ASQ), discusses recent developments in lab safety and how to address key challenges.
Subscribe today for access to
Articles and Reports
The end of the COVID-19 public health emergency on May 11 also brings certain flexibilities for labs and other providers to an end.
It’s imperative for labs to establish and maintain an active corporate compliance program that augments the actual scientific testing.
A new OIG Advisory Opinion sheds some light on how to properly structure these arrangements in a hospital inpatient setting.
Could paying the tuition costs of employees seeking certification put you at risk of violating the AKS?
Beware of Backlash When Restructuring Commission Arrangements for EKRA Sales Commissions & EKRA Liability Risks